Rita Nanda to Fluorodeoxyglucose F18
This is a "connection" page, showing publications Rita Nanda has written about Fluorodeoxyglucose F18.
Connection Strength
0.124
-
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003). J Clin Oncol. 2015 Aug 20; 33(24):2623-31.
Score: 0.124